Clinical Trial Update: Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the addition of olanzapine to fosaprepitant, ondansetron, and dexamethasone for preventing chemotherapy-induced nausea and vomiting i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Testicular Cancer

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)
• Ondansetron (ondansetron)
• olanzapine (olanzapine)

Snippet

Sponsor: Shi Yanxia | Conditions: Olanzapine, CINV | Phase 3 | Status: UNKNOWN